Literature DB >> 9658277

Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease.

N Gormley1, M R Rizwan.   

Abstract

Psychotic symptoms occur commonly in Alzheimer's disease (AD), predict a more rapid rate of cognitive decline and increase the risk of aggressive behaviour. Seventy patients with probable AD, recruited from an old age psychiatry service, were assessed to determine the prevalence and clinical correlates of delusions and hallucinations. Psychiatric symptoms were measured using the Behavioural Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD), Hamilton Rating Scale for depression (HRSD) and the Depressive Signs Scale (DSS). Thirty-four per cent of the sample experienced delusions and 11% hallucinations in the previous month. Men were more likely than women to have experienced psychotic symptoms. Psychotic and non-psychotic groups did not differ in age, age at illness onset, dementia severity, HRSD or DSS scores. This study confirms the high prevalence of psychotic symptoms in AD patients encountered in clinical practice, and suggests that psychosis and depression represent independent behavioural disturbances in AD.

Entities:  

Mesh:

Year:  1998        PMID: 9658277     DOI: 10.1002/(sici)1099-1166(199806)13:6<410::aid-gps787>3.0.co;2-s

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  5 in total

1.  An initial study of modifiable and non-modifiable factors for late-life psychosis.

Authors:  Obiora E Onwuameze; Susan K Schultz; Sergio Paradiso
Journal:  Int J Psychiatry Med       Date:  2011       Impact factor: 1.210

2.  Cerebral correlates of psychotic symptoms in Alzheimer's disease.

Authors:  M S Mega; L Lee; I D Dinov; F Mishkin; A W Toga; J L Cummings
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

3.  Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism.

Authors:  Patricia A Wilkosz; Chowdari Kodavali; Elise A Weamer; Sachiko Miyahara; Oscar L Lopez; Vishwajit L Nimgaonkar; Steven T DeKosky; Robert A Sweet
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-12-05       Impact factor: 3.568

4.  On Covid-19 and mental health: An observational study on depression, anxiety, and loneliness during the second lockdown in patients with Alzheimer disease.

Authors:  Mohamad El Haj; Claire Boutoleau-Bretonnière; Philippe Allain; Dimitrios Kapogiannis; Guillaume Chapelet; Karim Gallouj
Journal:  Medicine (Baltimore)       Date:  2022-05-06       Impact factor: 1.817

Review 5.  Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.

Authors:  Jeremy Koppel; Blaine S Greenwald
Journal:  Neuropsychiatr Dis Treat       Date:  2014-11-24       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.